ADAR1 Capital Management, LLC

CIK 1940272
Transactions on file
49
Open-market buys
43
Win rate (buys)
91%
43 scored
Avg % since filing (buys)
+26.0%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-09-082026-09-03TENX
TENAX THERAPEUTICS, INC.
10%
Buy900,000$1.60M+4.4%open →
2026-09-022026-09-02TENX
TENAX THERAPEUTICS, INC.
10%
Buy187,704$337.6K+3.4%open →
2026-09-022026-09-01TENX
TENAX THERAPEUTICS, INC.
10%
Buy179,058$321.6K+3.6%open →
2026-09-022026-08-31TENX
TENAX THERAPEUTICS, INC.
10%
Buy403,571$722.6K+3.9%open →
2026-08-252026-08-24TENX
TENAX THERAPEUTICS, INC.
10%
Buy107,374$188.4K+6.0%open →
2026-08-252026-08-21TENX
TENAX THERAPEUTICS, INC.
10%
Buy716,369$1.27M+5.2%open →
2026-08-252026-08-20TENX
TENAX THERAPEUTICS, INC.
10%
Buy202,124$359.5K+4.6%open →
2026-08-032026-07-31NXTC
NextCure, Inc.
10%
Buy8,003$38.4K+68.1%open →
2026-08-032026-07-31NXTC
NextCure, Inc.
10%
Buy25,000$124.5K+62.0%open →
2026-08-032026-07-31NXTC
NextCure, Inc.
10%
Buy3,300$16.4K+62.2%open →
2026-08-032026-07-30NXTC
NextCure, Inc.
10%
Buy77,850$385.8K+62.8%open →
2026-08-032026-07-30NXTC
NextCure, Inc.
10%
Buy100,000$490.0K+64.7%open →
2026-08-032026-07-30NXTC
NextCure, Inc.
10%
Buy25,000$120.3K+67.7%open →
2026-08-032026-07-30NXTC
NextCure, Inc.
10%
Buy20,000$100.0K+61.4%open →
2026-08-032026-07-30NXTC
NextCure, Inc.
10%
Buy20,000$100.0K+61.4%open →
2026-08-032026-07-30NXTC
NextCure, Inc.
10%
Buy50,000$248.6K+62.3%open →
2026-07-292026-07-29NXTC
NextCure, Inc.
10%
Buy1,600$8.0K+61.4%open →
2026-07-292026-07-29NXTC
NextCure, Inc.
10%
Buy1,810$9.1K+61.4%open →
2026-07-292026-07-28NXTC
NextCure, Inc.
10%
Buy6,400$31.7K+63.0%open →
2026-07-292026-07-27NXTC
NextCure, Inc.
10%
Buy7,798$39.0K+61.4%open →
2026-07-172026-07-15INM
InMed Pharmaceuticals Inc.
10%
Buy1,000$1.6K-5.5%open →
2026-05-212026-05-19INM
InMed Pharmaceuticals Inc.
10%
Buy200,000$299.8K-1.9%open →
2026-05-212026-05-19INM
InMed Pharmaceuticals Inc.
10%
Buy200,000$312.1K-5.8%open →
2026-05-212026-05-19INM
InMed Pharmaceuticals Inc.
10%
Buy68,551$109.7K-8.1%open →
2026-05-212026-05-19RLYB
Rallybio Corp
10%
Buy200$2.8K+17.1%open →
2026-05-212026-05-19RLYB
Rallybio Corp
10%
Buy10,000$139.8K+15.6%open →
2026-05-212026-05-18RLYB
Rallybio Corp
10%
Buy6,009$84.0K+15.6%open →
2026-05-162026-05-15RLYB
Rallybio Corp
10%
Buy200$2.8K+15.8%open →
2026-05-162026-05-15RLYB
Rallybio Corp
10%
Buy100$1.4K+17.1%open →
2026-05-162026-05-13RLYB
Rallybio Corp
10%
Buy75,178$1.05M+15.4%open →
2026-05-162026-05-13RLYB
Rallybio Corp
10%
Buy4,081$56.3K+17.1%open →
2026-05-142026-05-12RLYB
Rallybio Corp
10%
Buy800$11.1K+16.9%open →
2026-05-142026-05-11RLYB
Rallybio Corp
10%
Buy19,900$278.6K+15.4%open →
2026-05-142026-05-11RLYB
Rallybio Corp
10%
Buy25,000$350.0K+15.4%open →
2026-05-142026-05-11RLYB
Rallybio Corp
10%
Buy5,100$71.4K+15.4%open →
2025-04-112025-04-09KROS
Keros Therapeutics, Inc.
10%
Buy74,333$767.9K+7.3%open →
2025-04-112025-04-09KROS
Keros Therapeutics, Inc.
10%
Buy18,560$174.5K+17.9%open →
2025-04-112025-04-09KROS
Keros Therapeutics, Inc.
10%
Buy16,365$153.8K+17.9%open →
2025-04-112025-04-09KROS
Keros Therapeutics, Inc.
10%
Buy325,000$3.20M+12.4%open →
2025-04-112025-04-09KROS
Keros Therapeutics, Inc.
10%
Buy500,000$5.17M+7.3%open →
2025-06-242025-06-20KROS
Keros Therapeutics, Inc.
10%
X200$14.0K-84.2%open →
2025-06-242025-06-20KROS
Keros Therapeutics, Inc.
10%
X100$6.0K-81.5%open →
2025-06-242025-06-20KROS
Keros Therapeutics, Inc.
10%
X1,400$98.0K-84.2%open →
2026-05-072026-05-05RLYB
Rallybio Corp
10%
Buy35,101$491.3K+15.5%open →
2026-05-072026-05-04RLYB
Rallybio Corp
10%
Buy116,904$1.63M+15.7%open →
2026-05-072026-05-04RLYB
Rallybio Corp
10%
Buy3,900$54.2K+16.3%open →
2025-10-152025-10-15KROS
Keros Therapeutics, Inc.
10%
Sale743,358$13.19M-37.6%open →
2025-10-152025-10-15KROS
Keros Therapeutics, Inc.
10%
Sale254,669$4.52M-37.6%open →
2025-10-152025-10-15KROS
Keros Therapeutics, Inc.
10%
Sale4,391,237$77.94M-37.6%open →